A Novel Oral Natural Extract for the Treatment of Senile Purpura
Not Applicable
- Conditions
- PURPURA
- Registration Number
- NCT01183910
- Lead Sponsor
- Nexgen Dermatologics, Inc.
- Brief Summary
A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
- Patients with evidence of purpura on physical exam
Exclusion Criteria
- Preexisting condition that would not allow the patients to take oral calcium supplement
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method IMPROVEMENT IN PATIENT'S SKIN APPEARANCE WITH SENILE PURPURA 6 WEEKS
- Secondary Outcome Measures
Name Time Method ADVERSE EFFECTS IN PATIENTS WITH SENILE PURPURA TAKING THIS MEDICATION 6 WEEKS
Trial Locations
- Locations (1)
Berlin Center of Medical Aesthetics
🇺🇸Boynton Beach, Florida, United States
Berlin Center of Medical Aesthetics🇺🇸Boynton Beach, Florida, United States